辅助生殖技术受孕与自然受孕新生儿重症监护病房患儿基因谱比较
该横断面研究基于中国新生儿基因组计划多中心数据集,纳入535例辅助生殖技术受孕和1316例自然受孕的疑似遗传病NICU新生儿,均行全外显子组测序或靶向临床外显子组测序检测致病或可能致病的单核苷酸变异(SNV)和拷贝数变异(CNV)。辅助生殖技术组基因诊断率10.1%(54例),自然受孕组13.2%(174例),两组总体诊断率(OR 0.74;95%CI 0.53-1.02)、SNV比例(63.0% vs 69.0%;OR 0.68;95%CI 0.46-1.00)、CNV比例(37.0% vs 31.0%;OR 0.91;95%CI 0.54-1.53)及新发变异比例(75.9% vs 64.4%;OR 0.89;95%CI 0.62-1.30)均相似。提示对辅助生殖技术受孕的NICU疑似遗传病患儿,基因检测策略可与自然受孕患儿一致。
要点
- 辅助生殖技术受孕NICU疑似遗传病患儿基因诊断率10.1%(54/535),自然受孕患儿13.2%(174/1316),OR 0.74(95%CI 0.53-1.02)。
- 辅助生殖技术组检出SNV 34例(63.0%)、CNV 20例(37.0%);自然受孕组SNV 120例(69.0%)、CNV 54例(31.0%),OR分别为0.68(95%CI 0.46-1.00)和0.91(95%CI 0.54-1.53)。
- 新发变异比例辅助生殖技术组75.9%(41/54) vs 自然受孕组64.4%(112/174),OR 0.89(95%CI 0.62-1.30)。
- 两组总体诊断率、变异类型构成及新发变异比例差异均未达统计学显著(95%CI均包含1)。
适用人群与场景
- Ⅲ级和Ⅳ级NICU中疑似遗传病的活产新生儿,包括辅助生殖技术受孕者535例(男319例,59.6%)和自然受孕者1316例(男772例,58.7%)。
- 辅助生殖技术组数据收集于2016年8月1日至2021年12月31日,自然受孕组收集于2016年8月1日至2018年12月31日,数据分析和于2021年9月至2023年1月进行。
处置流程与药物剂量
- 对每例患儿行全外显子组测序或靶向临床外显子组测序,检测致病或可能致病的单核苷酸变异(SNV)和拷贝数变异(CNV)。
研究设计与关键结果
- 研究类型:横断面研究,基于中国新生儿基因组计划(复旦大学附属儿科医院管理的多中心国家新生儿基因组数据集),纳入535例辅助生殖技术受孕和1316例自然受孕的疑似遗传病NICU新生儿。
- 辅助生殖技术组基因诊断54例(10.1%),其中SNV 34例(63.0%)、CNV 20例(37.0%);自然受孕组基因诊断174例(13.2%),其中SNV 120例(69.0%)、CNV 54例(31.0%)。
- 总体诊断率辅助生殖技术组 vs 自然受孕组:10.1% vs 13.2%,OR 0.74(95%CI 0.53-1.02)。
- SNV比例辅助生殖技术组 vs 自然受孕组:63.0% vs 69.0%,OR 0.68(95%CI 0.46-1.00);CNV比例:37.0% vs 31.0%,OR 0.91(95%CI 0.54-1.53)。
- 新发变异比例辅助生殖技术组 vs 自然受孕组:75.9%(41/54) vs 64.4%(112/174),OR 0.89(95%CI 0.62-1.30)。
证据类型、等级与局限
- 证据类型:横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在同一临床环境下,辅助生殖技术受孕与自然受孕的活产NICU新生儿总体基因诊断率和新发变异发生率相似;原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: A growing number of children are conceived with assisted reproductive technology (ART). However, there is a lack of studies systematically analyzing the genetic landscape of live-born children conceived through ART who need intensive care in the neonatal period.
OBJECTIVE: To investigate the incidence and type of molecular defects among neonates conceived through ART who are in intensive care units (NICUs) with suspected genetic conditions.
DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional study using data from the China Neonatal Genomes Project, a multicenter national neonatal genome data set managed by the Children's Hospital of Fudan University. All participants were from level III and IV NICUs and included 535 neonates conceived through ART with suspected genetic conditions, with data collected between August 1, 2016, and December 31, 2021, and 1316 naturally conceived neonates with suspected genetic conditions in the same clinical settings, with data collected between August 1, 2016, and December 31, 2018. The data were analyzed between September 2021 and January 2023.
EXPOSURES: Whole-exome sequencing or target clinical exome sequencing with pathogenic or likely pathogenic single-nucleotide variant (SNV) and copy number variation (CNV) detection was performed for each individual.
MAIN OUTCOMES AND MEASURES: The primary outcome was the molecular diagnostic yield, mode of inheritance, spectrum of genetic events, and incidence of de novo variants.
RESULTS: A total of 535 neonates conceived through ART (319 boys [59.6%]) and 1316 naturally conceived neonates (772 boys [58.7%]) were included. A genetic diagnosis was established for 54 patients conceived through ART (10.1%), including 34 patients with SNVs (63.0%) and 20 with CNVs (37.0%). In the non-ART group, 174 patients (13.2%) received a genetic diagnosis, including 120 patients with SNVs (69.0%) and 54 with CNVs (31.0%). The overall diagnostic yield was comparable between the ART group and the naturally conceived neonates (10.1% vs 13.2%; odds ratio [OR], 0.74; 95% CI, 0.53-1.02), as was the proportion of SNVs (63.0% vs 69.0%; OR, 0.68; 95% CI, 0.46-1.00) and CNVs (37.0% vs 31.0%; OR, 0.91; 95% CI, 0.54-1.53) detected by sequencing. Furthermore, the proportions of de novo variants in the ART group and the non-ART group were similar (75.9% [41 of 54] vs 64.4% [112 of 174]; OR, 0.89; 95% CI, 0.62-1.30).
CONCLUSIONS AND RELEVANCE: This cross-sectional study of neonates in NICUs suggests that the overall genetic diagnostic yield and the incidence of de novo variants were similar between live-born neonates conceived through ART and naturally conceived neonates in the same settings.
参考来源
- Huang Z, Xiao F, Xiao H, et al. Comparison of Genetic Profiles of Neonates in Intensive Care Units Conceived With or Without Assisted Reproductive Technology. JAMA Netw Open. 2023. PMID: 37014641. doi:10.1001/jamanetworkopen.2023.6537
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。